Keratin Gene Mutations in Disorders of Human Skin and Its Appendages

Overview

Journal Arch Biochem Biophys

Publisher Elsevier

Specialties Biochemistry
Biophysics

Date 2010 Dec 24

PMID 21176769

Citations 71

Authors

Jean Christopher Chamcheu

Imtiaz A Siddiqui

Deeba N Syed

Vaqar M Adhami

Mirjana Liovic

Hasan Mukhtar

Affiliations

Soon will be listed here.

Abstract

Keratins, the major structural protein of all epithelia are a diverse group of cytoskeletal scaffolding proteins that form intermediate filament networks, providing structural support to keratinocytes that maintain the integrity of the skin. Expression of keratin genes is usually regulated by differentiation of the epidermal cells within the stratifying squamous epithelium. Amongst the 54 known functional keratin genes in humans, about 22 different genes including, the cornea, hair and hair follicle-specific keratins have been implicated in a wide range of hereditary diseases. The exact phenotype of each disease usually reflects the spatial expression level and the types of mutated keratin genes, the location of the mutations and their consequences at sub-cellular levels as well as other epigenetic and/or environmental factors. The identification of specific pathogenic mutations in keratin disorders formed the basis of our understanding that led to re-classification, improved diagnosis with prognostic implications, prenatal testing and genetic counseling in severe keratin genodermatoses. Molecular defects in cutaneous keratin genes encoding for keratin intermediate filaments (KIFs) causes keratinocytes and tissue-specific fragility, accounting for a large number of genetic disorders in human skin and its appendages. These diseases are characterized by keratinocytes fragility (cytolysis), intra-epidermal blistering, hyperkeratosis, and keratin filament aggregation in severely affected tissues. Examples include epidermolysis bullosa simplex (EBS; K5, K14), keratinopathic ichthyosis (KPI; K1, K2, K10) i.e. epidermolytic ichthyosis (EI; K1, K10) and ichthyosis bullosa of Siemens (IBS; K2), pachyonychia congenita (PC; K6a, K6b, K16, K17), epidermolytic palmo-plantar keratoderma (EPPK; K9, (K1)), monilethrix (K81, K83, K86), ectodermal dysplasia (ED; K85) and steatocystoma multiplex. These keratins also have been identified to have roles in apoptosis, cell proliferation, wound healing, tissue polarity and remodeling. This review summarizes and discusses the clinical, ultrastructural, molecular genetics and biochemical characteristics of a broad spectrum of keratin-related genodermatoses, with special clinical emphasis on EBS, EI and PC. We also highlight current and emerging model tools for prognostic future therapies. Hopefully, disease modeling and in-depth understanding of the molecular pathogenesis of the diseases may lead to the development of novel therapies for several hereditary cutaneous diseases.

Citing Articles

Mechanics of cell sheets: plectin as an integrator of cytoskeletal networks.

Outla Z, Prechova M, Korelova K, Gemperle J, Gregor M Open Biol. 2025; 15(1):240208.

PMID: 39875099 PMC: 11774597. DOI: 10.1098/rsob.240208.

Vulvar Epidermolytic Hyperkeratosis: A Comprehensive Systematic Review of Case Reports and Series.

Cristescu M, Cozma E, Beiu C, Tudose I, Ali S, Bobirca A J Clin Med. 2025; 14(1.

PMID: 39797176 PMC: 11721915. DOI: 10.3390/jcm14010094.

Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.

van der Velden J, van Gisbergen M, Kamps M, Janssen R, Diercks G, Steijlen P J Dermatol. 2024; 51(9):1180-1186.

PMID: 39072839 PMC: 11484123. DOI: 10.1111/1346-8138.17395.

AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach.

Rosignoli S, Lustrino E, Conci A, Fabrizi A, Rinaldo S, Latella M Nucleic Acids Res. 2024; 52(W1):W29-W38.

PMID: 38795068 PMC: 11223865. DOI: 10.1093/nar/gkae419.

A novel heterozygous frameshift mutation in the gene responsible for an uncommon phenotype of pachyonychia congenita: One case report and review of literature.

Liang J, Li R, Liu C, Cai Y, Liu Y, Chen P Heliyon. 2024; 10(5):e27195.

PMID: 38468954 PMC: 10926126. DOI: 10.1016/j.heliyon.2024.e27195.

References

Connors J, Rahil A, Smith F, McLean W, Milstone L . Delayed-onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16. Br J Dermatol. 2001; 144(5):1058-62. DOI: 10.1046/j.1365-2133.2001.04199.x. View

McLean W, Rugg E, Lunny D, Morley S, Lane E, Swensson O . Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet. 1995; 9(3):273-8. DOI: 10.1038/ng0395-273. View

McLean W, Smith F, Cassidy A . Insights into genotype-phenotype correlation in pachyonychia congenita from the human intermediate filament mutation database. J Investig Dermatol Symp Proc. 2005; 10(1):31-6. DOI: 10.1111/j.1087-0024.2005.10205.x. View

Khavari P, Rollman O, Vahlquist A . Cutaneous gene transfer for skin and systemic diseases. J Intern Med. 2002; 252(1):1-10. DOI: 10.1046/j.1365-2796.2002.00995.x. View

Wong P, Takahashi K, Gu C, Babinet C, Coulombe P . Introducing a null mutation in the mouse K6alpha and K6beta genes reveals their essential structural role in the oral mucosa. J Cell Biol. 2000; 150(4):921-8. PMC: 2175283. DOI: 10.1083/jcb.150.4.921. View

Tsubota A, Akiyama M, Kanitakis J, Sakai K, Nomura T, Claudy A . Mild recessive bullous congenital ichthyosiform erythroderma due to a previously unidentified homozygous keratin 10 nonsense mutation. J Invest Dermatol. 2008; 128(7):1648-52. DOI: 10.1038/sj.jid.5701257. View

Uitto J, Richard G, McGrath J . Diseases of epidermal keratins and their linker proteins. Exp Cell Res. 2007; 313(10):1995-2009. PMC: 2578874. DOI: 10.1016/j.yexcr.2007.03.029. View

Rugg E, Horn H, Smith F, Wilson N, Hill A, Magee G . Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol. 2006; 127(3):574-80. DOI: 10.1038/sj.jid.5700571. View

Terron-Kwiatkowski A, Terrinoni A, Didona B, Melino G, Atherton D, Irvine A . Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene. Br J Dermatol. 2004; 150(6):1096-103. DOI: 10.1111/j.1365-2133.2004.05967.x. View

10.

Smith F, Sandilands A, McLean W . Molecular genetics methods for human intermediate filament diseases. Methods Cell Biol. 2005; 78:131-61. DOI: 10.1016/s0091-679x(04)78006-1. View

11.

Sprecher E, Ishida-Yamamoto A, Becker O, Marekov L, Miller C, Steinert P . Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol. 2001; 116(4):511-9. DOI: 10.1046/j.1523-1747.2001.01292.x. View

12.

Liovic M, Lee B, Tomic-Canic M, DAlessandro M, Bolshakov V, Lane E . Dual-specificity phosphatases in the hypo-osmotic stress response of keratin-defective epithelial cell lines. Exp Cell Res. 2008; 314(10):2066-75. DOI: 10.1016/j.yexcr.2008.02.020. View

13.

Szeverenyi I, Cassidy A, Chung C, Lee B, Common J, Ogg S . The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat. 2007; 29(3):351-60. DOI: 10.1002/humu.20652. View

14.

Chipev C, Steinert P, Woodworth C . Characterization of an immortalized cell line from a patient with epidermolytic hyperkeratosis. J Invest Dermatol. 1996; 106(3):385-90. DOI: 10.1111/1523-1747.ep12343322. View

15.

Tsubota A, Akiyama M, Sakai K, Goto M, Nomura Y, Ando S . Keratin 1 gene mutation detected in epidermal nevus with epidermolytic hyperkeratosis. J Invest Dermatol. 2007; 127(6):1371-4. DOI: 10.1038/sj.jid.5700712. View

16.

DiGiovanna J, Bale S . Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol. 1994; 130(8):1026-35. View

17.

Rothnagel J, Greenhalgh D, Gagne T, Longley M, Roop D . Identification of a calcium-inducible, epidermal-specific regulatory element in the 3'-flanking region of the human keratin 1 gene. J Invest Dermatol. 1993; 101(4):506-13. DOI: 10.1111/1523-1747.ep12365886. View

18.

Covello S, Smith F, Sillevis Smitt J, Paller A, Munro C, Jonkman M . Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol. 1998; 139(3):475-80. DOI: 10.1046/j.1365-2133.1998.02413.x. View

19.

Suga Y, Duncan K, Heald P, Roop D . A novel helix termination mutation in keratin 10 in annular epidermolytic ichthyosis, a variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol. 1998; 111(6):1220-3. DOI: 10.1046/j.1523-1747.1998.00451.x. View

20.

Kimonis V, DiGiovanna J, Yang J, Doyle S, Bale S, Compton J . A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol. 1994; 103(6):764-9. DOI: 10.1111/1523-1747.ep12412771. View